ArticlebioRxiv : the preprint server for biology2026
Annotation-Based Gene-Peak Links Improve Regulatory Network Prediction of Gene Expression in Human Kidney Multi-Omics.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Linking distal regulatory elements to their target genes is a central problem for interpreting chromatin accessibility and other non-coding genomic data. Proximity-based mapping is convenient but ignores three-dimensional enhancer-promoter architecture and can misassign long-range regulatory effects. Correlation-based approaches can also miss regulatory links because of limited statistical power and restrictive distance or significance thresholds. Single-cell and single-nucleus multi-omic datasets, such as 10x Multiome profiles that jointly measure chromatin accessibility and gene expression in the same cells or nuclei, now provide a way to evaluate gene-peak linkage strategies by testing how well linked accessibility features predict gene expression. Existing methods often focus on scoring individual enhancer-gene pairs. In this study, we proposed and constructed a fast annotation-based candidate gene-peak network and tested whether it improves downstream prediction of gene expression. Methods: We first built a unified gene-peak regulatory network by integrating enhancer-based, promoter-based, and proximity-based linkage strategies. We then used single-cell multiome data from the Kidney Precision Medicine Project (KPMP) 10x Multiome cohort to evaluate whether the proposed links captured regulatory signals. We aggregated RNA expression and ATAC accessibility at the cell-type cluster level and trained predictive models to evaluate how well different linkage strategies could explain gene expression based on accessibility. Model performance was compared between annotation-based (including both enhancer- and promoter-based links) and proximity-based gene-peak links using testing R Results: In the strict regime (1,704 genes with ≥20 peaks assigned by the nearest-TSS rule and ≥10 annotated enhancer-based peaks), the annotation-based model consistently achieved higher testing R Conclusions: Using human kidney 10x Multiome data, we show that a fast annotation-based gene-peak linkage framework can improve prediction of gene expression from chromatin accessibility compared with conventional approaches. These results support the use of biologically informed enhancer and promoter annotations when constructing candidate gene regulatory networks. Our framework also showed concordance with the correlation-based Signac LinkPeaks method while providing broader coverage and greater computational efficiency. We have implemented these annotation-based linkage methods in the GPlinksR R package, providing a fast and scalable tool for constructing regulatory networks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.